Term
|
Definition
< 4 ng/mL is healthy. Varies.
>25% free PSA.
Prostate cancer correlation. |
|
|
Term
|
Definition
| hepatoma, some ovarian and testes. |
|
|
Term
|
Definition
| Secreted by various including breast, lung, colorectal, and stomach cancers. Mainly used to monitor recurrence of cancer but it is a useful marker for colorectal cancer. NOt a screening tool |
|
|
Term
| Thryoglobulin (tumor marker) |
|
Definition
| check for recurrence after surgery. It is elevated in grave's disease, and thryoditis. Anti thyroglobulins are also screened. |
|
|
Term
|
Definition
| glycotic enzyme. Formed in neuroendocrine system, and it is elevated in neuroblastoma and small lung cancer. |
|
|
Term
|
Definition
| polypeptide hormone, made by C cells in thryoid to regulate calcium. Elevated in thyroid medullary carcinoma. Helps diagnosis, monitor treatment, and reccurence. |
|
|
Term
| H factor. Nuclear matrix protein |
|
Definition
|
|
Term
|
Definition
| oncogene product (genetic marker). Breast cancers mainly followed by GI and ovarian. |
|
|
Term
|
Definition
| Unique Beta subunit. Elevated in germ cell cancers, trophoblastic, and others. |
|
|
